Seed Expands into Children’s Health with Launch of Its First Clinically Studied Pediatric Synbiotic

PDS-08™ reflects Seed's mission to bring scientific rigor, efficacy, and novel data generation to the global category of probiotics LOS ANGELES, April 13, 2022 /PRNewswire/ -- Seed, the microbiome science company pioneering clinically and scientifically studied next-generation probiotics,...

Click to view original post